ginsenoside rh2 has been researched along with Colorectal Cancer in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liang, L; Sun, P; Wang, J; Wang, Z; Xu, M; Yuan, Y; Zhang, Y | 1 |
| Jiang, GS; Liu, GW; Liu, YH; Ren, WD | 1 |
| Bai, LP; Chan, KM; Chan, RW; Dong, H; Guo, J; Guo, Y; Hsiao, WW; Jiang, ZH; Kam, RK; Kong, AN; Law, BY; Leung, EL; Liang, X; Liu, L; Wang, J; Wang, R; Wong, VK; Yen, FG; Yu, Z; Zhang, W; Zhou, H | 1 |
| Bin Kang, K; Cho, CH; Chung, JW; Han, S; Jeong, AJ; Kim, BH; Lee, H; Sung, SH; Yang, H; Ye, SK; Yi, EH | 1 |
| Du, W; He, TC; Li, B; Searle, J; Wang, CZ; Yuan, CS; Zhao, J | 1 |
5 other study(ies) available for ginsenoside rh2 and Colorectal Cancer
| Article | Year |
|---|---|
20(S)-ginsenoside Rh2 as agent for the treatment of LMN-CRC via regulating epithelial-mesenchymal transition.
Topics: Antineoplastic Agents; Cadherins; Cell Line, Tumor; Cell Movement; Cell Proliferation; China; Colorectal Neoplasms; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Ginsenosides; Humans; Lymphatic Metastasis; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Signal Transduction; Vimentin | 2020 |
The reversal effect of Ginsenoside Rh2 on drug resistance in human colorectal carcinoma cells and its mechanism.
Topics: ATP Binding Cassette Transporter, Subfamily B; Carcinoma; Cell Cycle; Cell Movement; Cell Proliferation; Colorectal Neoplasms; Drug Resistance, Neoplasm; Drug Synergism; Fluorouracil; Gene Expression; Ginsenosides; Humans; Multidrug Resistance-Associated Proteins; Phytotherapy; Tumor Cells, Cultured | 2018 |
Rh2E2, a novel metabolic suppressor, specifically inhibits energy-based metabolism of tumor cells.
Topics: Animals; Apoptosis; Azoxymethane; Carcinoma, Lewis Lung; Cell Line; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Dextran Sulfate; Drugs, Chinese Herbal; Energy Metabolism; Ginsenosides; Humans; Immunoblotting; Mice, Inbred C57BL; Mitochondrial Proteins; Molecular Structure; Neoplasms; Proteomics; S Phase Cell Cycle Checkpoints | 2016 |
Ginsenoside 20(S)-Rh2 exerts anti-cancer activity through targeting IL-6-induced JAK2/STAT3 pathway in human colorectal cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Colorectal Neoplasms; Doxorubicin; Drug Synergism; Ginsenosides; Humans; Interleukin-6; Janus Kinase 2; Matrix Metalloproteinases; Signal Transduction; STAT3 Transcription Factor | 2016 |
Ginsenoside Rh2 induces apoptosis and paraptosis-like cell death in colorectal cancer cells through activation of p53.
Topics: Acetylcysteine; Amino Acid Chloromethyl Ketones; Apoptosis; Apoptosis Regulatory Proteins; Blotting, Western; Caspase Inhibitors; Caspases; Cell Death; Cell Line, Tumor; Cell Survival; Colorectal Neoplasms; Cysteine Proteinase Inhibitors; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Free Radical Scavengers; Ginsenosides; HCT116 Cells; HEK293 Cells; Humans; Mutation; NF-kappa B; Reactive Oxygen Species; Signal Transduction; Tumor Suppressor Protein p53; Vacuoles | 2011 |